[go: up one dir, main page]

HUE033499T2 - Use of combination antimicrobials - Google Patents

Use of combination antimicrobials Download PDF

Info

Publication number
HUE033499T2
HUE033499T2 HUE07718439A HUE07718439A HUE033499T2 HU E033499 T2 HUE033499 T2 HU E033499T2 HU E07718439 A HUE07718439 A HU E07718439A HU E07718439 A HUE07718439 A HU E07718439A HU E033499 T2 HUE033499 T2 HU E033499T2
Authority
HU
Hungary
Prior art keywords
therapy
combination
vaginal
treatment
adhesion
Prior art date
Application number
HUE07718439A
Other languages
English (en)
Hungarian (hu)
Inventor
Christian Noe
Marion Noe-Letschnig
Original Assignee
Christian Noe
Marion Noe-Letschnig
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Christian Noe, Marion Noe-Letschnig filed Critical Christian Noe
Publication of HUE033499T2 publication Critical patent/HUE033499T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
HUE07718439A 2006-05-12 2007-05-10 Use of combination antimicrobials HUE033499T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT8262006 2006-05-12

Publications (1)

Publication Number Publication Date
HUE033499T2 true HUE033499T2 (en) 2017-12-28

Family

ID=37903545

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE07718439A HUE033499T2 (en) 2006-05-12 2007-05-10 Use of combination antimicrobials

Country Status (19)

Country Link
US (2) US8552042B2 (sl)
EP (2) EP3192507B1 (sl)
JP (1) JP2009536926A (sl)
CN (1) CN101484162A (sl)
AU (1) AU2007250502B2 (sl)
CA (1) CA2651726C (sl)
CY (1) CY1119094T1 (sl)
DK (1) DK2018164T3 (sl)
ES (1) ES2627268T3 (sl)
HR (1) HRP20170793T1 (sl)
HU (1) HUE033499T2 (sl)
LT (1) LT2018164T (sl)
NO (2) NO342103B1 (sl)
PL (1) PL2018164T3 (sl)
PT (1) PT2018164T (sl)
RS (1) RS56044B1 (sl)
RU (1) RU2008148977A (sl)
SI (1) SI2018164T1 (sl)
WO (1) WO2007131253A2 (sl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI23311A (sl) * 2010-03-19 2011-09-30 Kemijski inštitut Farmacevtska kombinacija acetilsalicilne kisline in protiglivne substance za uničevanje ali inhibicijo rasti in replikacije gliv
CN102210649A (zh) * 2010-04-09 2011-10-12 上海医药科技发展有限公司 一种两性霉素b乳膏及其制备方法
FR2993179B1 (fr) * 2012-07-13 2016-01-08 Lesaffre & Cie Levure saccharomyces cerevisiae pour prevenir et/ou traiter les mycoses vaginales
CN103044408A (zh) * 2013-01-21 2013-04-17 万礼 在治疗恶性肿瘤时应用的伊曲康唑或其盐及其组合物
US8883747B1 (en) 2013-10-09 2014-11-11 Craig W. Carver Topical antifungal compositions and methods of use thereof
LT3244889T (lt) * 2015-01-13 2020-08-10 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Farmacinė kompozicija, skirta mikozės gydymui
CN104920360B (zh) * 2015-06-18 2017-04-12 青岛农业大学 丁苯羟酸在制备用于防治由植物病原菌引起的植物病害的杀菌剂中的用途
EP3482744A1 (de) 2017-11-14 2019-05-15 ProFem GmbH Emulsionen zur topischen behandlung urogenitaler und dermaler infektionen
HUE065778T2 (hu) 2017-11-14 2024-06-28 Profem Gmbh Emulziók bõr- és nyálkahártya-fertõzések helyi kezelésére
EP3482743A1 (de) 2017-11-14 2019-05-15 ProFem GmbH Emulsionen zur behandlung von scheideninfektionen
FR3089788B1 (fr) * 2018-12-17 2020-12-18 Lesaffre & Cie Souche de levure Saccharomyces cerevisiae pour le traitement et/ou la prévention de candidoses oropharyngées
US20250302821A1 (en) * 2022-05-12 2025-10-02 St. Jude Children's Research Hospital, Inc. Synergistic antifungal composition and method
WO2024187210A1 (de) 2023-03-15 2024-09-19 Profem Gmbh Kombinationsarzneimittel zur behandlung und reduktion der rückfallraten vaginaler mykosen

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6471823A (en) * 1987-09-12 1989-03-16 Rohto Pharma Sustained remedy for vaginal candidiasis
US5087620A (en) * 1990-05-17 1992-02-11 Bristol-Myers Squibb Co. Controlled dermal penetration enhancement using imidazoles
ES2079994B1 (es) 1992-10-07 1996-08-01 Cusi Lab Formulacion farmaceutica a base de polimixina-trimetoprim y un agente antiinflamatorio para su utilizacion topica oftalmica y otica.
JPH09510185A (ja) * 1993-12-23 1997-10-14 ザ、プロクター、エンド、ギャンブル、カンパニー 組織モイスチャライジング及び抗菌組成物
US6416779B1 (en) * 1997-06-11 2002-07-09 Umd, Inc. Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
US6159977A (en) 1998-11-16 2000-12-12 Astan, Inc. Therapeutic anti-fungal nail preparation
AU3372200A (en) * 1999-02-19 2000-09-04 Ligocyte Pharmaceuticals, Inc. Antibodies against hydrophobic proteins that are protective against candidiasis
JP4767418B2 (ja) * 1999-03-24 2011-09-07 エムエスエイチ ファーマ，インコーポレイテッド アルファ−メラノサイト−刺激ホルモン由来の抗菌性アミノ酸配列
GB0108082D0 (en) 2001-03-30 2001-05-23 Novartis Consumer Health Sa Topical composition
US20030181384A1 (en) 2001-09-06 2003-09-25 Podolsky Daniel K. Methods and compositions for treating vaginal, cervical, and uterine epithelial lesions
US20040142910A1 (en) * 2002-10-21 2004-07-22 Aegis Biosciences Llc Sulfonated styrene copolymers for medical uses
WO2004060283A2 (en) * 2002-12-16 2004-07-22 Nitromed, Inc. Nitrosated and nitrosylated rapamycin compounds, compositions and methods of use
DE602004029465D1 (de) 2003-06-25 2010-11-18 Hisamitsu Pharmaceutical Co Externes Präparat zur Behandlung von Fusspilz
WO2005009342A2 (en) 2003-07-16 2005-02-03 Pharmacia Corporation Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith
ES2237298B1 (es) * 2003-07-16 2006-11-01 Italfarmaco, S.A. Formulaciones mucoadhesivas semisolidas.
TWI290051B (en) 2004-05-28 2007-11-21 Schering Corp Particulate-stabilized injectable pharmaceutical compositions of Posaconazole

Also Published As

Publication number Publication date
US8552042B2 (en) 2013-10-08
WO2007131253A3 (de) 2008-11-27
US20090208558A1 (en) 2009-08-20
EP2018164A2 (de) 2009-01-28
US20140030312A1 (en) 2014-01-30
NO20180083A1 (no) 2009-02-10
AU2007250502B2 (en) 2013-11-28
HRP20170793T1 (hr) 2017-10-06
SI2018164T1 (sl) 2017-07-31
PL2018164T3 (pl) 2017-08-31
NO20085181L (no) 2009-02-10
NO342103B1 (no) 2018-03-26
CA2651726A1 (en) 2007-11-22
CA2651726C (en) 2015-12-15
RU2008148977A (ru) 2010-06-20
ES2627268T3 (es) 2017-07-27
DK2018164T3 (en) 2017-06-12
PT2018164T (pt) 2017-06-12
LT2018164T (lt) 2017-07-10
US8815925B2 (en) 2014-08-26
EP2018164B1 (de) 2017-03-01
RS56044B1 (sr) 2017-09-29
EP3192507B1 (de) 2020-07-08
CN101484162A (zh) 2009-07-15
NO345064B1 (no) 2020-09-14
AU2007250502A1 (en) 2007-11-22
WO2007131253A2 (de) 2007-11-22
EP3192507A1 (de) 2017-07-19
JP2009536926A (ja) 2009-10-22
CY1119094T1 (el) 2018-01-10

Similar Documents

Publication Publication Date Title
HUE033499T2 (en) Use of combination antimicrobials
RU2533458C2 (ru) Композиции, содежащие берберин или его аналоги для лечения кожных заболеваний, связанных с розацеа или с покраснением лица
KR20120013404A (ko) 화상 치료 조성물 및 방법
US9662360B2 (en) Treatment of herpes, pseudomonas, staph, and hepatitis
WO2019130215A1 (en) Cannabis compositions for the treatment of inflammatory skin disorders
CN110753698A (zh) 用于治疗真菌感染的方法
US20240366550A1 (en) Drug for Treating Prostatitis or Benign Prostatic Hyperplasia (BPH)
JP5872673B2 (ja) 皮膚疾患を治療するための方法
CN111135141A (zh) 一种鼻腔用复合水凝胶制备方法
MD4802C1 (ro) Utilizarea derivatului de glutaramidă pentru tratarea afecţiunilor, asociate cu activitatea aberantă a citokinelor
CN111867580B (zh) 用于预防或改善脱发的包含有效成分董尼酮的组合物
RU2358744C1 (ru) Способ лечения онихомикоза
AU2017261517B2 (en) Use of combination preparations, comprising antimycotics
CN114366732B (zh) 泰妙菌素在制备用于治疗银屑病的药物中的应用
RU2789515C1 (ru) Фармацевтическая композиция на основе аквакомплекса глицеросольвата титана в сочетании с L-аргинином для лечения воспалительных заболеваний слизистой оболочки полости рта
CN120437267A (zh) 沙丁鱼肽组合物在制备防治唇炎的药物中的新用途
RU2147440C1 (ru) Обезболивающее и противозудное средство
WO2023220396A1 (en) Methods of treatment using a dual specificity tyrosine-phosphorylation-regulated kinase 1a (dyrk1a) inhibitor
CN101703504B (zh) 一种阴道用药物组合物
CN116036105A (zh) 一种治疗淋巴水肿的药物运用
TW202448432A (zh) 肌萎縮性側索硬化症（ａｌｓ）的治療
EP0293529A1 (en) Admixtures of diflunisal and tromethamine
CN1751681A (zh) 治疗慢性鼻窦炎的阿司咪唑新剂型
HK1145626A1 (en) Pharmaceutical composition for treating arthritis and the preparation method thereof